BMP antagonists: Their roles in development and involvement in pathophysiology

Cytokine and Growth Factor Reviews

Volumn 16, Issue 3 SPEC. ISS., 2005, Pages 309-317

  Yanagita, Motoko ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Cystine knot; Ectodin; Sclerostin; USAG 1; Wise

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CHORDIN; NOGGIN; OSTEOGENIC PROTEIN 1; SCLEROSTIN; SECRETORY PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UTERINE SENSITIZATION ASSOCIATED GENE 1; WNT PROTEIN;

BONE DENSITY; BONE DEVELOPMENT; BONE DISEASE; BONE MASS; CELL MATURATION; GASTRULATION; KIDNEY DISEASE; MORPHOGENESIS; MUTATION; PATHOPHYSIOLOGY; PHYLOGENY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SENSITIZATION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE; UTERUS;

EID: 21344437987     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2005.02.007     Document Type: Article

References (104)

1. J. Massague, and Y.G. Chen Controlling TGF-β signaling Genes Dev 14 6 2000 627 644
2. E. Canalis, A.N. Economides, and E. Gazzerro Bone morphogenetic proteins, their antagonists, and the skeleton Endocr Rev 24 2 2003 218 235
3. A.H. Reddi Interplay between bone morphogenetic proteins and cognate binding proteins in bone and cartilage development: noggin, chordin and DAN Arthritis Res 3 1 2001 1 5
4. L. Attisano, and J.L. Wrana Signal transduction by members of the transforming growth factor-β superfamily Cytokine Growth Factor Rev 7 4 1996 327 339
5. A.H. Reddi Bone morphogenetic proteins and skeletal development: the kidney-bone connection Pediatr Nephrol 14 7 2000 598 601
6. M.R. Urist Bone: formation by autoinduction Science 150 698 1965 893 899
7. J.M. Wozney, V. Rosen, A.J. Celeste, L.M. Mitsock, M.J. Whitters, and R.W. Kriz Novel regulators of bone formation: molecular clones and activities Science 242 4885 1988 1528 1534
8. B.L. Hogan Bone morphogenetic proteins in development Curr Opin Genet Dev 6 4 1996 432 438
9. E.A. Wang Bone morphogenetic proteins (BMPs): therapeutic potential in healing bony defects Trends Biotechnol 11 9 1993 379 383
10. S. Klahr The bone morphogenetic proteins (BMPs). Their role in renal fibrosis and renal function J Nephrol 16 2 2003 179 185
11. K.A. Hruska, G. Saab, L.R. Chaudhary, C.O. Quinn, R.J. Lund, and K. Surendran Kidney-bone, bone-kidney, and cell-cell communications in renal osteodystrophy Semin Nephrol 24 1 2004 25 38
12. M. Zeisberg, G.A. Muller, and R. Kalluri Are there endogenous molecules that protect kidneys from injury? The case for bone morphogenic protein-7 (BMP-7) Nephrol Dial Transplant 19 4 2004 759 761
13. K. Miyazono, K. Kusanagi, and H. Inoue Divergence and convergence of TGF-β/BMP signaling J Cell Physiol 187 3 2001 265 276
14. J.H. Morse, Z. Deng, and J.A. Knowles Genetic aspects of pulmonary arterial hypertension Ann Med 33 9 2001 596 603
15. C.F. Chang, S.Z. Lin, Y.H. Chiang, M. Morales, J. Chou, and P. Lein Intravenous administration of bone morphogenetic protein-7 after ischemia improves motor function in stroke rats Stroke 34 2 2003 558 564
16. J.R. Howe, J.L. Bair, M.G. Sayed, M.E. Anderson, F.A. Mitros, and G.M. Petersen Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis Nat Genet 28 2 2001 184 187
17. O. Avsian-Kretchmer, and A.J. Hsueh Comparative genomic analysis of the eight-membered ring cystine-knot-containing bone morphogenetic protein antagonists Mol Endocrinol 18 1 2004 1 12
18. D.S. Wagner, and M.C. Mullins Modulation of BMP activity in dorsal-ventral pattern formation by the chordin and ogon antagonists Dev Biol 245 1 2002 109 123
19. O. Wessely, E. Agius, M. Oelgeschlager, E.M. Pera, and E.M. De Robertis Neural induction in the absence of mesoderm: β-catenin-dependent expression of secreted BMP antagonists at the blastula stage in Xenopus Dev Biol 234 1 2001 161 173
20. D.A. Lim, A.D. Tramontin, J.M. Trevejo, D.G. Herrera, J.M. Garcia-Verdugo, and A. Alvarez-Buylla Noggin antagonizes BMP signaling to create a niche for adult neurogenesis Neuron 28 3 2000 713 726
21. U.A. Vitt, S.Y. Hsu, and A.J. Hsueh Evolution and classification of cystine-knot-containing hormones and related extracellular signaling molecules Mol Endocrinol 15 5 2001 681 694
22. D.R. Hsu, A.N. Economides, X. Wang, P.M. Eimon, and R.M. Harland The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities Mol Cell 1 5 1998 673 683
23. J.J. Pearce, G. Penny, and J. Rossant A mouse Cerberus/Dan-related gene family Dev Biol 209 1 1999 98 110
24. L.Z. Topol, M. Marx, D. Laugier, N.N. Bogdanova, N.V. Boubnov, and P.A. Clausen Identification of drm, a novel gene whose expression is suppressed in transformed cells and which can inhibit growth of normal but not transformed cells in culture Mol Cell Biol 17 8 1997 4801 4810
25. M. Oelgeschlager, J. Larrain, D. Geissert, and E.M. De Robertis The evolutionarily conserved BMP-binding protein twisted gastrulation promotes BMP signaling Nature 405 6788 2000 757 763
26. J.J. Ross, O. Shimmi, P. Vilmos, A. Petryk, H. Kim, and K. Gaudenz Twisted gastrulation is a conserved extracellular BMP antagonist Nature 410 6827 2001 479 483
27. I.C. Scott, I.L. Blitz, W.N. Pappano, S.A. Maas, K.W. Cho, and D.S. Greenspan Homologues of Twisted gastrulation are extracellular cofactors in antagonism of BMP signaling Nature 410 6827 2001 475 478
28. C. Chang, D.A. Holtzman, S. Chau, T. Chickering, E.A. Woolf, and L.M. Holmgren Twisted gastrulation can function as a BMP antagonist Nature 410 6827 2001 483 487
29. M.S. Dionne, L.J. Brunet, P.M. Eimon, and R.M. Harland Noggin is required for correct guidance of dorsal root ganglion axons Dev Biol 251 2 2002 283 293
30. J. Groppe, J. Greenwald, E. Wiater, J. Rodriguez-Leon, A.N. Economides, and W. Kwiatkowski Structural basis of BMP signaling inhibition by the cystine-knot protein Noggin Nature 420 6916 2002 636 642
31. S.M. Warren, L.J. Brunet, R.M. Harland, A.N. Economides, and M.T. Longaker The BMP antagonist noggin regulates cranial suture fusion Nature 422 6932 2003 625 629
32. C. Minabe-Saegusa, H. Saegusa, M. Tsukahara, and S. Noguchi Sequence and expression of a novel mouse gene PRDC (protein related to DAN and Cerberus) identified by a gene trap approach Dev Growth Differ 40 3 1998 343 353
33. L.Z. Topol, W.S. Modi, S. Koochekpour, and D.G. Blair DRM/GREMLIN (CKTSF1B1) maps to human chromosome 15 and is highly expressed in adult and fetal brain Cytogenet Cell Genet 89 1-2 2000 79 84
34. L.Z. Topol, B. Bardot, Q. Zhang, J. Resau, E. Huillard, and M. Marx Biosynthesis, post-translation modification, and functional characterization of Drm/Gremlin J Biol Chem 275 12 2000 8785 8793
35. E. Bell, I. Munoz-Sanjuan, C.R. Altmann, A. Vonica, and A.H. Brivanlou Cell fate specification and competence by Coco, a maternal BMP TGF-β and Wnt inhibitor Development 130 7 2003 1381 1389
36. T. Ozaki, and S. Sakiyama Molecular cloning and characterization of a cDNA showing negative regulation in v-src-transformed 3Y1 rat fibroblasts Proc Natl Acad Sci USA 90 7 1993 2593 2597
37. T. Ozaki, and S. Sakiyama Tumor-suppressive activity of N03 gene product in v-src-transformed rat 3Y1 fibroblasts Cancer Res 54 3 1994 646 648
38. M. Yanagita, M. Oka, T. Watabe, H. Iguchi, A. Niida, and S. Takahashi USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidney Biochem Biophys Res Commun 316 2 2004 490 500
39. D.G. Simmons, and T.G. Kennedy Uterine sensitization-associated gene-1: a novel gene induced within the rat endometrium at the time of uterine receptivity/sensitization for the decidual cell reaction Biol Reprod 67 5 2002 1638 1645
40. N. Kusu, J. Laurikkala, M. Imanishi, H. Usui, M. Konishi, and A. Miyake Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity J Biol Chem 278 26 2003 24113 24117
41. D.G. Winkler, M.K. Sutherland, J.C. Geoghegan, C. Yu, T. Hayes, and J.E. Skonier Osteocyte control of bone formation via sclerostin, a novel BMP antagonist EMBO J 22 23 2003 6267 6276
42. R.L. van Bezooijen, B.A. Roelen, A. Visser, L. van der Wee-Pals, E. de Wilt, and M. Karperien Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist J Exp Med 199 6 2004 805 814
43. M.N. Helder, E. Ozkaynak, K.T. Sampath, F.P. Luyten, V. Latin, and H. Oppermann Expression pattern of osteogenic protein-1 (bone morphogenetic protein-7) in human and mouse development J Histochem Cytochem 43 10 1995 1035 1044
44. S. Vukicevic, A. Stavljenic, and M. Pecina Discovery and clinical applications of bone morphogenetic proteins Eur J Clin Chem Clin Biochem 33 10 1995 661 671
45. S. Vukicevic, J.B. Kopp, F.P. Luyten, and T.K. Sampath Induction of nephrogenic mesenchyme by osteogenic protein 1 (bone morphogenetic protein 7) Proc Natl Acad Sci USA 93 17 1996 9021 9026
46. E. Ozkaynak, P.N. Schnegelsberg, and H. Oppermann Murine osteogenic protein (OP-1): high levels of mRNA in kidney Biochem Biophys Res Commun 179 1 1991 116 123
47. G. Luo, C. Hofmann, A.L. Bronckers, M. Sohocki, A. Bradley, and G. Karsenty BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning Genes Dev 9 22 1995 2808 2820
48. A.T. Dudley, K.M. Lyons, and E.J. Robertson A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye Genes Dev 9 22 1995 2795 2807
49. S.E. Gould, M. Day, S.S. Jones, and H. Dorai BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells Kidney Int 61 1 2002 51 60
50. S.N. Wang, J. Lapage, and R. Hirschberg Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy J Am Soc Nephrol 12 11 2001 2392 2399
51. K.A. Hruska Treatment of chronic tubulointerstitial disease: a new concept Kidney Int 61 5 2002 1911 1922
52. J. Morrissey, K. Hruska, G. Guo, S. Wang, Q. Chen, and S. Klahr Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function J Am Soc Nephrol 13 Suppl. 1 2002 S14 S21
53. P.H. Dube, M.M. Almanzar, K.S. Frazier, W.K. Jones, M.F. Charette, and A. Paredes Osteogenic protein-1: gene expression and treatment in rat remnant kidney model Toxicol Pathol 32 4 2004 384 392
54. M.M. Almanzar, K.S. Frazier, P.H. Dube, A.I. Piqueras, W.K. Jones, and M.F. Charette Osteogenic protein-1 mRNA expression is selectively modulated after acute ischemic renal injury J Am Soc Nephrol 9 8 1998 1456 1463
55. S. Vukicevic, V. Basic, D. Rogic, N. Basic, M.S. Shih, and A. Shepard Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat J Clin Invest 102 1 1998 202 214
56. K.A. Hruska, G. Guo, M. Wozniak, D. Martin, S. Miller, and H. Liapis Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction Am J Physiol Renal Physiol 279 1 2000 F130 F143
57. S. Wang, Q. Chen, T.C. Simon, F. Strebeck, L. Chaudhary, and J. Morrissey Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy Kidney Int 63 6 2003 2037 2049
58. M. Zeisberg, C. Bottiglio, N. Kumar, Y. Maeshima, F. Strutz, and G.A. Muller Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models Am J Physiol Renal Physiol 285 6 2003 F1060 F1067
59. M. Zeisberg, J. Hanai, H. Sugimoto, T. Mammoto, D. Charytan, and F. Strutz BMP-7 counteracts TGF-β1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury Nat Med 9 7 2003 964 968
60. M.E. Brunkow, J.C. Gardner, J. Van Ness, B.W. Paeper, B.R. Kovacevich, and S. Proll Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine-knot-containing protein Am J Hum Genet 68 3 2001 577 589
61. J. Laurikkala, Y. Kassai, L. Pakkasjarvi, I. Thesleff, and N. Itoh Identification of a secreted BMP antagonist, ectodin, integrating BMP, FGF, and SHH signals from the tooth enamel knot Dev Biol 264 1 2003 91 105
62. R. Harland, and J. Gerhart Formation and function of Spemann's organizer Annu Rev Cell Dev Biol 13 1997 611 667
63. R.F. O'Shaughnessy, W. Yeo, J. Gautier, C.A. Jahoda, and A.M. Christiano The WNT signaling modulator, Wise, is expressed in an interaction-dependent manner during hair-follicle cycling J Invest Dermatol 123 4 2004 613 621
64. V.A. Botchkarev, N.V. Botchkareva, M. Nakamura, O. Huber, K. Funa, and R. Lauster Noggin is required for induction of the hair follicle growth phase in postnatal skin FASEB J 15 12 2001 2205 2214
65. V.A. Botchkarev, N.V. Botchkareva, W. Roth, M. Nakamura, L.H. Chen, and W. Herzog Noggin is a mesenchymally derived stimulator of hair-follicle induction Nat Cell Biol 1 3 1999 158 164
66. N. Itasaki, C.M. Jones, S. Mercurio, A. Rowe, P.M. Domingos, and J.C. Smith Wise, a context-dependent activator and inhibitor of Wnt signaling Development 130 18 2003 4295 4305
67. S.Y. Sokol Analysis of dishevelled signaling pathways during Xenopus development Curr Biol 6 11 1996 1456 1467
68. K. Tamai, M. Semenov, Y. Kato, R. Spokony, C. Liu, and Y. Katsuyama LDL-receptor-related proteins in Wnt signal transduction Nature 407 6803 2000 530 535
69. I. del Barco Barrantes, G. Davidson, H.J. Grone, H. Westphal, and C. Niehrs Dkk1 and noggin cooperate in mammalian head induction Genes Dev 17 18 2003 2239 2244
70. L. Grotewold, and U. Ruther The Wnt antagonist Dickkopf-1 is regulated by Bmp signaling and c-Jun and modulates programmed cell death EMBO J 21 5 2002 966 975
71. S. Piccolo, E. Agius, L. Leyns, S. Bhattacharyya, H. Grunz, and T. Bouwmeester The head inducer Cerberus is a multifunctional antagonist of Nodal BMP and Wnt signals Nature 397 6721 1999 707 710
72. Y. Gong, R.B. Slee, N. Fukai, G. Rawadi, S. Roman-Roman, and A.M. Reginato LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development Cell 107 4 2001 513 523
73. L. Fischer, G. Boland, and R.S. Tuan Wnt-3A enhances bone morphogenetic protein-2-mediated chondrogenesis of murine C3H10T1/2 mesenchymal cells J Biol Chem 277 34 2002 30870 30878
74. G. Bain, T. Muller, X. Wang, and J. Papkoff Activated β-catenin induces osteoblast differentiation of C3H10T1/2 cells and participates in BMP2 mediated signal transduction Biochem Biophys Res Commun 301 1 2003 84 91
75. D.G. Winkler, M.S. Kung Sutherland, E. Ojala, E. Turcott, J.C. Geoghegan, and D. Shpektor Sclerostin inhibition of Wnt-3a-induced C3H10T1/2 cell differentiation is Indirect and mediated by BMP proteins J Biol Chem 2004
76. D.G. Winkler, C. Yu, J.C. Geoghegan, E.W. Ojala, J.E. Skonier, and D. Shpektor Noggin and sclerostin bone morphogenetic protein antagonists form a mutually inhibitory complex J Biol Chem 279 35 2004 36293 36298
77. E. Stanley, C. Biben, S. Kotecha, L. Fabri, S. Tajbakhsh, and C.C. Wang DAN is a secreted glycoprotein related to Xenopus Cerberus Mech Dev 77 2 1998 173 184
78. H. Enomoto, T. Ozaki, E. Takahashi, N. Nomura, S. Tabata, and H. Takahashi Identification of human DAN gene, mapping to the putative neuroblastoma tumor suppressor locus Oncogene 9 10 1994 2785 2791
79. M.S. Dionne, W.C. Skarnes, and R.M. Harland Mutation and analysis of Dan, the founding member of the Dan family of transforming growth factor β antagonists Mol Cell Biol 21 2 2001 636 643
80. T. Bouwmeester, S. Kim, Y. Sasai, B. Lu, and E.M. De Robertis Cerberus is a head-inducing secreted factor expressed in the anterior endoderm of Spemann's organizer Nature 382 6592 1996 595 601
81. C. Biben, E. Stanley, L. Fabri, S. Kotecha, M. Rhinn, and C. Drinkwater Murine Cerberus homologue mCer-1: a candidate anterior patterning molecule Dev Biol 194 2 1998 135 151
82. J.A. Belo, D. Bachiller, E. Agius, C. Kemp, A.C. Borges, and S. Marques Cerberus-like is a secreted BMP and nodal antagonist not essential for mouse development Genesis 26 4 2000 265 270
83. S. Sudo, O. Avsian-Kretchmer, L.S. Wang, and A.J. Hsueh Protein related to DAN and Cerberus is a bone morphogenetic protein antagonist that participates in ovarian paracrine regulation J Biol Chem 279 22 2004 23134 23141
84. O. Michos, L. Panman, K. Vintersten, K. Beier, R. Zeller, and A. Zuniga Gremlin-mediated BMP antagonism induces the epithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis Development 131 14 2004 3401 3410
85. M.K. Khokha, D. Hsu, L.J. Brunet, M.S. Dionne, and R.M. Harland Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning Nat Genet 34 3 2003 303 307
86. R. McMahon, M. Murphy, M. Clarkson, M. Taal, H.S. Mackenzie, and C. Godson IHG-2, a mesangial cell gene induced by high glucose, is human gremlin. Regulation by extracellular glucose concentration, cyclic mechanical strain, and transforming growth factor-β1 J Biol Chem 275 14 2000 9901 9904
87. W.C. Smith, and R.M. Harland Expression cloning of noggin, a new dorsalizing factor localized to the Spemann organizer in Xenopus embryos Cell 70 5 1992 829 840
88. T.M. Lamb, A.K. Knecht, W.C. Smith, S.E. Stachel, A.N. Economides, and N. Stahl Neural induction by the secreted polypeptide noggin Science 262 5134 1993 713 718
89. L.J. Brunet, J.A. McMahon, A.P. McMahon, and R.M. Harland Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton Science 280 5368 1998 1455 1457
90. J.A. McMahon, S. Takada, L.B. Zimmerman, C.M. Fan, R.M. Harland, and A.P. McMahon Noggin-mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite Genes Dev 12 10 1998 1438 1452
91. Y. Gong, D. Krakow, J. Marcelino, D. Wilkin, D. Chitayat, and R. Babul-Hirji Heterozygous mutations in the gene-encoding noggin affect human joint morphogenesis Nat Genet 21 3 1999 302 304
92. J. Marcelino, C.M. Sciortino, M.F. Romero, L.M. Ulatowski, R.T. Ballock, and A.N. Economides Human disease-causing NOG missense mutations: effects on noggin secretion, dimer formation, and bone morphogenetic protein binding Proc Natl Acad Sci USA 98 20 2001 11353 11358
93. X.B. Wu, Y. Li, A. Schneider, W. Yu, G. Rajendren, and J. Iqbal Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice J Clin Invest 112 6 2003 924 934
94. M.M. Cohen Jr. Craniosynostoses: phenotypic/molecular correlations Am J Med Genet 56 3 1995 334 339
95. A.O. Wilkie Craniosynostosis: genes and mechanisms Hum Mol Genet 6 10 1997 1647 1656
96. S. Piccolo, Y. Sasai, B. Lu, and E.M. De Robertis Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4 Cell 86 4 1996 589 598
97. Y. Sasai, B. Lu, S. Piccolo, and E.M. De Robertis Endoderm induction by the organizer-secreted factors chordin and noggin in Xenopus animal caps EMBO J 15 17 1996 4547 4555
98. J. Larrain, D. Bachiller, B. Lu, E. Agius, S. Piccolo, and E.M. De Robertis BMP-binding modules in chordin: a model for signaling regulation in the extracellular space Development 127 4 2000 821 830
99. F.C. Wardle, J.V. Welch, and L. Dale Bone morphogenetic protein 1 regulates dorsal-ventral patterning in early Xenopus embryos by degrading chordin, a BMP4 antagonist Mech Dev 86 1-2 1999 75 85
100. D. Bachiller, J. Klingensmith, C. Kemp, J.A. Belo, R.M. Anderson, and S.R. May The organizer factors chordin and noggin are required for mouse forebrain development Nature 403 6770 2000 658 661
101. D. Bachiller, J. Klingensmith, N. Shneyder, U. Tran, R. Anderson, and J. Rossant The role of chordin/Bmp signals in mammalian pharyngeal development and DiGeorge syndrome Development 130 15 2003 3567 3578
102. T. Nosaka, S. Morita, H. Kitamura, H. Nakajima, F. Shibata, and Y. Morikawa Mammalian twisted gastrulation is essential for skeleto-lymphogenesis Mol Cell Biol 23 8 2003 2969 2980
103. D. Graf, S. Nethisinghe, D.B. Palmer, A.G. Fisher, and M. Merkenschlager The developmentally regulated expression of twisted gastrulation reveals a role for bone morphogenetic proteins in the control of T cell development J Exp Med 196 2 2002 163 171
104. R. Kalluri, and E.G. Neilson Epithelial-mesenchymal transition and its implications for fibrosis J Clin Invest 112 12 2003 1776 1784